All changes for the tissue Anatomical System (4331)
Identifier
Name
Type
Tissues
Organism
Gene
Data
Actions
DAA633
Chronic lower respiratory diseases
Pathological
respiratory system
Human
—
SeriesMorbidity
DAA1013
Chronic Obstructive Pulmonary Disease (Female)
Pathological
lung
Human
—
SeriesIncidence
DAA821
Chronic obstructive pulmonary disease incidence increases
Pathological
lung
Human
—
—
DAA1012
Chronic Obstructive Pulmonary Disease (Male)
Pathological
lung
Human
—
SeriesIncidence
DAA1213
Circadian GH change
Physiological
plasma
Human
GH1
—
DAA1212
Circadian plasma melatonin flattened
Physiological
plasma
Human
—
—
DAA1214
Circadian prolactin flattened
Physiological
plasma
Human
PRL
—
DAA1198
Circadian Rhythm
Physiological
whole body
Human
—
—
DAA2055
Circulating miR-21 expression increases
Molecular
blood
Human
—
—
DAA426
citrate lyase beta like
Molecular
skeletal muscle
Human
CLYBL
6.0% Decrease Gene Expression Level
DAA1854
citrate synthase
Molecular
skeletal muscle
Mouse
Cs
4.0% Increase Gene Expression Level
DAA1703
CKLF-like MARVEL transmembrane domain containing 8
Molecular
lung
Mouse
Cmtm8
5.0% Decrease Gene Expression Level
DAA1746
clathrin interactor 1
Molecular
muscle
Mouse
Clint1
5.0% Increase Gene Expression Level
DAA263
claudin 8
Molecular
kidney
Human
CLDN8
17.0% Decrease Gene Expression Level
DAA2203
Clusterin increases with age
Molecular
frontal lobe
Human
CLU
56.5% Increase Gene Expression Level
DAA2201
Clusterin increases with age
Molecular
frontal lobe
Human
CLU
25.5% Increase Gene Expression Level
DAA2202
Clusterin increases with age
Molecular
frontal lobe
Human
CLU
30.9% Increase Gene Expression Level
DAA2193
Clusterin increases with age
Molecular
parietal lobe
Human
CLU
47.9% Increase Gene Expression Level
DAA2192
Clusterin increases with age
Molecular
parietal lobe
Human
CLU
23.5% Increase Gene Expression Level
DAA2191
Clusterin increases with age
Molecular
parietal lobe
Human
CLU
22.5% Increase Gene Expression Level
DAA2180
Clusterin increases with age
Molecular
hippocampus
Human
CLU
58.9% Increase Gene Expression Level
DAA2179
Clusterin increases with age
Molecular
hippocampus
Human
CLU
41.7% Increase Gene Expression Level
DAA2178
Clusterin increases with age
Molecular
hippocampus
Human
CLU
33.1% Increase Gene Expression Level
DAA2168
Clusterin increases with age
Molecular
temporal lobe
Human
CLU
25.9% Increase Gene Expression Level
DAA1655
coagulation factor XIII, A1 subunit
Molecular
lung
Mouse
F13a1
8.0% Increase Gene Expression Level
Identifier | Name | Type | Tissues | Organism | Gene | Data | Actions |
---|---|---|---|---|---|---|---|
DAA633 | Chronic lower respiratory diseases | Pathological | respiratory system | Human | — | SeriesMorbidity | |
DAA1013 | Chronic Obstructive Pulmonary Disease (Female) | Pathological | lung | Human | — | SeriesIncidence | |
DAA821 | Chronic obstructive pulmonary disease incidence increases | Pathological | lung | Human | — | — | |
DAA1012 | Chronic Obstructive Pulmonary Disease (Male) | Pathological | lung | Human | — | SeriesIncidence | |
DAA1213 | Circadian GH change | Physiological | plasma | Human | GH1 | — | |
DAA1212 | Circadian plasma melatonin flattened | Physiological | plasma | Human | — | — | |
DAA1214 | Circadian prolactin flattened | Physiological | plasma | Human | PRL | — | |
DAA1198 | Circadian Rhythm | Physiological | whole body | Human | — | — | |
DAA2055 | Circulating miR-21 expression increases | Molecular | blood | Human | — | — | |
DAA426 | citrate lyase beta like | Molecular | skeletal muscle | Human | CLYBL | 6.0% Decrease Gene Expression Level | |
DAA1854 | citrate synthase | Molecular | skeletal muscle | Mouse | Cs | 4.0% Increase Gene Expression Level | |
DAA1703 | CKLF-like MARVEL transmembrane domain containing 8 | Molecular | lung | Mouse | Cmtm8 | 5.0% Decrease Gene Expression Level | |
DAA1746 | clathrin interactor 1 | Molecular | muscle | Mouse | Clint1 | 5.0% Increase Gene Expression Level | |
DAA263 | claudin 8 | Molecular | kidney | Human | CLDN8 | 17.0% Decrease Gene Expression Level | |
DAA2203 | Clusterin increases with age | Molecular | frontal lobe | Human | CLU | 56.5% Increase Gene Expression Level | |
DAA2201 | Clusterin increases with age | Molecular | frontal lobe | Human | CLU | 25.5% Increase Gene Expression Level | |
DAA2202 | Clusterin increases with age | Molecular | frontal lobe | Human | CLU | 30.9% Increase Gene Expression Level | |
DAA2193 | Clusterin increases with age | Molecular | parietal lobe | Human | CLU | 47.9% Increase Gene Expression Level | |
DAA2192 | Clusterin increases with age | Molecular | parietal lobe | Human | CLU | 23.5% Increase Gene Expression Level | |
DAA2191 | Clusterin increases with age | Molecular | parietal lobe | Human | CLU | 22.5% Increase Gene Expression Level | |
DAA2180 | Clusterin increases with age | Molecular | hippocampus | Human | CLU | 58.9% Increase Gene Expression Level | |
DAA2179 | Clusterin increases with age | Molecular | hippocampus | Human | CLU | 41.7% Increase Gene Expression Level | |
DAA2178 | Clusterin increases with age | Molecular | hippocampus | Human | CLU | 33.1% Increase Gene Expression Level | |
DAA2168 | Clusterin increases with age | Molecular | temporal lobe | Human | CLU | 25.9% Increase Gene Expression Level | |
DAA1655 | coagulation factor XIII, A1 subunit | Molecular | lung | Mouse | F13a1 | 8.0% Increase Gene Expression Level |